A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
Introduction: Protein deimination, defined as the post-translational conversion of protein-bound arginine to citrulline, is carried out by a family of 5 calcium-dependent enzymes, the peptidylarginine deiminases (PADs) and has been linked to various cancers. Cellular microvesicle (MV) release, which...
Main Authors: | Sharad Kholia, Samireh Jorfi, Paul R. Thompson, Corey P. Causey, Anthony P. Nicholas, Jameel M. Inal, Sigrun Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2015-06-01
|
Series: | Journal of Extracellular Vesicles |
Subjects: | |
Online Access: | http://www.journalofextracellularvesicles.net/index.php/jev/article/view/26192/pdf_29 |
Similar Items
-
Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy
by: Uchini S. Kosgodage, et al.
Published: (2017-05-01) -
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
by: Uchini S. Kosgodage, et al.
Published: (2018-08-01) -
Peptidylarginine Deiminase (PAD) and Post-Translational Protein Deimination—Novel Insights into Alveolata Metabolism, Epigenetic Regulation and Host–Pathogen Interactions
by: Árni Kristmundsson, et al.
Published: (2021-02-01) -
Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases
by: Marie-Claire Méchin, et al.
Published: (2020-01-01) -
Putative Roles for Peptidylarginine Deiminases in COVID-19
by: Elif Damla Arisan, et al.
Published: (2020-06-01)